Clinical Trial Update: A Study in Leukemia Patients With Karonudib [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Karonudib is underway for leukemia, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Karonudib (TH1579)

Snippet

Sponsor: Thomas Helleday Foundation | Conditions: Leukemia | Phase 1 | Status: RECRUITING